Biohaven Ltd.
BHVN· NYSE
Filed Aug 10, 2026 · 10-Q · 41 days after period end · 0001935979-26-000066
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Net Income | -$137.31M | -$198.15M | -$319.77M | -$90.35M |
| EPS Diluted | -$0.91 | -$1.94 | -$3.64 | -$1.32 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biohaven Ltd. · CIK 1935979 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Aug 10, 2026 · 41 d after period end